Spotlight Medical Validates AI Assay for Low-Risk High-Risk Breast Cancer
The assay identifies a biologically low-risk subgroup inside clinically high-risk sufferers, with outcomes just like stage I illness, doubtlessly sparing 30,000 girls every year from pointless remedy intensification. Highlight Medical as we speak introduced that the Journal of Scientific Oncology has revealed a peer-reviewed research describing a clinicopathologic assay that identifies a sizeable subgroup of sufferers labelled scientific…
